I don't see anything about a trial either, however, just the fact that they are listing Leronlimab as a drug being used to treat in a clinical research application is exciting (to say the least) and one has to wonder what's next and when regarding Leronlimab and Montiefiore. I don't think they would have Leronlimab on their web page if they were not using it. They must have considerable data to be willing to even mention it as a "smart molecule" used in their treatment for lung failure. It would be nice to know more and hopefully that information will be put forth soon.